Physician profile
Heather C Pickett
NPI 1528231123
$1,477.20
in general payments reported to CMS, 2019-2025
19 companies · $388 in 2025
The $388 reported for 2025 was more than what 84% of Women'S Health Care, Ambulatory providers received nationally (typical 2025 total: $102).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $224 · 2023: $228 · 2024: $506 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,121.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $229.80 | 2024-2025 | Veozah |
| Novo Nordisk INC | $203.90 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Organon LLC | $134.85 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $133.36 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $129.22 | 2023-2025 | |
| Exeltis, USA INC. | $119.66 | 2023-2025 | Slynd |
| Abbvie INC. | $90.95 | 2021-2023 | |
| Pfizer INC. | $86.82 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $75.14 | 2024-2025 | Myfembree, Gemtesa |
| Coopersurgical, INC. | $47.74 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Lilly USA, LLC | $38.66 | 2025 | Zepbound |
| Boston Scientific Corporation | $35.25 | 2023 | Upsylon |
| Mylan Pharmaceuticals INC. | $32.22 | 2022 | |
| Optumhealth Care Solutions, LLC | $26.27 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Hologic Sales and Service, LLC | $23.82 | 2023 | Myosure Tissue Removal Device |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $22.62 | 2021 | |
| Amgen INC. | $17.58 | 2025 | Evenity |
| Scynexis, INC. | $15.69 | 2022 | |
| Smith+Nephew, INC. | $13.65 | 2024 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Pickett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.